Christopher Patusky - Aug 17, 2023 Form 4 Insider Report for UNITED THERAPEUTICS Corp (UTHR)

Role
Director
Signature
/s/ John S. Hess, Jr. under Power of Attorney
Stock symbol
UTHR
Transactions as of
Aug 17, 2023
Transactions value $
-$280,180
Form type
4
Date filed
8/18/2023, 04:30 PM
Previous filing
Jul 17, 2023
Next filing
Nov 8, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UTHR Common Stock Options Exercise $176K +2K +118.76% $88.03 3.68K Aug 17, 2023 Direct F1
transaction UTHR Common Stock Disposed to Issuer -$456K -2K -54.29% $228.12 1.68K Aug 17, 2023 Direct F1
holding UTHR Common Stock 1.1K Aug 17, 2023 By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UTHR Share Tracking Award Options Exercise $0 -2K -50% $0.00 2K Aug 17, 2023 Common Stock 2K $88.03 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.
F2 Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.